Clever Leaves Holdings Inc. (CLVR): Price and Financial Metrics
GET POWR RATINGS... FREE!
CLVR POWR Grades
- CLVR scores best on the Growth dimension, with a Growth rank ahead of 61.53% of US stocks.
- The strongest trend for CLVR is in Growth, which has been heading down over the past 179 days.
- CLVR ranks lowest in Quality; there it ranks in the 4th percentile.
CLVR Stock Summary
- Clever Leaves Holdings Inc's market capitalization of $80,727,944 is ahead of only 13.16% of US-listed equities.
- Clever Leaves Holdings Inc's stock had its IPO on December 11, 2018, making it an older stock than merely 10.44% of US equities in our set.
- In terms of volatility of its share price, CLVR is more volatile than 98.68% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Clever Leaves Holdings Inc, a group of peers worth examining would be ISUN, CREX, OSW, OEG, and TRKA.
- CLVR's SEC filings can be seen here. And to visit Clever Leaves Holdings Inc's official web site, go to www.cleverleaves.com.
CLVR Valuation Summary
- CLVR's price/sales ratio is 16.8; this is 342.11% higher than that of the median Healthcare stock.
- Over the past 33 months, CLVR's EV/EBIT ratio has gone NA NA.
- Over the past 33 months, CLVR's price/sales ratio has gone NA NA.
Below are key valuation metrics over time for CLVR.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| CLVR | 2021-08-31 | 16.8 | 3.1 | -7.7 | -8.2 |
| CLVR | 2021-08-30 | 17.2 | 3.1 | -7.9 | -8.4 |
| CLVR | 2021-08-27 | 17.9 | 3.3 | -8.2 | -8.8 |
| CLVR | 2021-08-26 | 17.7 | 3.2 | -8.1 | -8.6 |
| CLVR | 2021-08-25 | 18.0 | 3.3 | -8.3 | -8.8 |
| CLVR | 2021-08-24 | 18.9 | 3.4 | -8.7 | -9.3 |
CLVR's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- CLVR has a Quality Grade of D, ranking ahead of 7.67% of graded US stocks.
- CLVR's asset turnover comes in at 0.095 -- ranking 266th of 681 Pharmaceutical Products stocks.
- 500 - Internal server error
The table below shows CLVR's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.095 | 0.618 | -0.384 |
| 2021-03-31 | 0.073 | 0.612 | -0.199 |
| 2020-12-31 | 0.086 | 0.612 | -0.185 |
| 2020-12-31 | 0.086 | 0.612 | -0.277 |
| 2020-09-30 | 0.029 | 0.529 | -0.026 |
| 2020-09-30 | 0.000 | NA | 0.001 |
CLVR Price Target
For more insight on analysts targets of CLVR, see our CLVR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $12.00 | Average Broker Recommendation | 1.5 (Moderate Buy) |
CLVR Stock Price Chart Interactive Chart >
CLVR Price/Volume Stats
| Current price | $1.04 | 52-week high | $12.40 |
| Prev. close | $1.08 | 52-week low | $0.91 |
| Day low | $1.01 | Volume | 333,606 |
| Day high | $1.06 | Avg. volume | 5,464,890 |
| 50-day MA | $1.57 | Dividend yield | N/A |
| 200-day MA | $4.34 | Market Cap | 31.33M |
Clever Leaves Holdings Inc. (CLVR) Company Bio
Clever Leaves Holdings, Inc. operates as a holding company. It produces pharmaceutical-grade cannabinoids. The company was founded on July 23, 2020 and is headquartered in New York, NY.
Latest CLVR News From Around the Web
Below are the latest news stories about Clever Leaves Holdings Inc that investors may wish to consider to help them evaluate CLVR as an investment opportunity.
Clever Leaves Expands Partnership With Cansativa; Cansativa Raises Up to $15 Million in Financing Led by Casa VerdeClever Leaves enters three-year commercial supply agreement with German distributor and wholesaler to enhance access into medicinal cannabis marketBOCA RATON, Fla. and FRANKFURT, Germany, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced the expansion of its partnership with German cannabis distributor and wholesaler Ca |
Clever Leaves'' Pharmaceutical-Grade Cannabis Extracts Reach Germany Via Ethypharm Partnership | BenzingaPharmaceutical-grade cannabinoids extracts produced by Clever Leaves Holdings Inc. (NASDAQ: |
Clever Leaves'' Pharmaceutical-Grade Cannabis Extracts Reach Germany Via Ethypharm PartnershipPharmaceutical-grade cannabinoids extracts produced by Clever Leaves Holdings Inc. (NASDAQ: CLVR ) will soon be available for distribution by its partner in Germany , Ethypharm GmbH , a European specialty pharmaceutical company. Following a March 2021 supply agreement signed by the two companies providing Ethypharm access to Clever Leaves Holdings EU GMP certified cannabis extracts , the shipment includes two products: a 100 mg CBD with 3 mg THC per gram formulation and a 200 mg CBD with 6 mg THC per gram formulation . “As the largest medical cannabis market in Europe and one of the most … Full story available on Benzinga.com |
Clever Leaves Holdings Begins Sales of Cannabis Extracts in Germany Through Ethypharm PartnershipProducts imported and to be commercially available in German pharmacies Products imported and to be commercially available in German pharmacies |
Cannabis Movers & Shakers: Ascend Wellness, MedMen, Clever Leaves, Palo Santo, GoldCannAscend Wellness Promotes Frank Perullo To President Ascend Wellness Holdings, Inc. (CSE: AAWH.U) (OTCQX: AAWH ) has promoted its co-founder and chief strategy officer, Frank Perullo, to president. At his new position, Perullo will be responsible for AWH''s day-to-day operations with the retail, sales and marketing as well as operations departments will report directly to Perullo going forward, in addition to his existing reports, the company said Monday. Abner Kurtin, founder and CEO of AWH will continue to lead the company and oversee Perullo, along with Dan Neville, chief financial officer, and Robin Debiase, chief people officer. “I can''t think of a better person to step into the President role than Frank, as we further develop our canopy, brand portfolio, and retail footprint in 20... |
CLVR Price Returns
| 1-mo | -34.59% |
| 3-mo | -8.77% |
| 6-mo | N/A |
| 1-year | -88.52% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -66.45% |
| 2021 | -65.17% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...